These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2435 related articles for article (PubMed ID: 33771638)

  • 1. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
    Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
    Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The traditional Chinese medicine formula Fufang-Zhenzhu-Tiaozhi protects myocardia from injury in diabetic minipigs with coronary heart disease.
    Song L; Zhang D; Guo C; Gu Z; Wang L; Yao YS; Wang H; Zeng Z; Wang W; Yang Y; Bei W; Rong X; Guo J
    Biomed Pharmacother; 2021 May; 137():111343. PubMed ID: 33761594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
    Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
    Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
    Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
    J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
    Wei S; Li J; Han DW; Fu Q; Hao F
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
    Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
    J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scutellariae Radix and Coptidis Rhizoma Improve Glucose and Lipid Metabolism in T2DM Rats via Regulation of the Metabolic Profiling and MAPK/PI3K/Akt Signaling Pathway.
    Cui X; Qian DW; Jiang S; Shang EX; Zhu ZH; Duan JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453687
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
    Zhou M; Liu X; Wu Y; Xiang Q; Yu R
    J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology combined with molecular docking and experimental verification to elucidate functional mechanism of Fufang Zhenzhu Tiaozhi against type 2 diabetes mellitus.
    Li B; Li X; Zeng Y; Zhou Z; Zhao D; Qin F; Zhang B; Yao W; Mao Y; Zhou L; Li K; Zhu Q; Rong X; Guo J
    J Biomol Struct Dyn; 2023 Nov; ():1-17. PubMed ID: 37942992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease.
    Yang YQ; Tan HB; Zhang XY; Zhang YZ; Lin QY; Huang MY; Lin ZY; Mo JZ; Zhang Y; Lan T; Bei WJ; Guo J
    J Ethnopharmacol; 2022 Jun; 292():115165. PubMed ID: 35247475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
    Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation.
    Shi H; Qiao F; Huang K; Lu W; Zhang X; Ke Z; Wu Y; Cao L; Chen Y
    J Ethnopharmacol; 2022 Oct; 296():115477. PubMed ID: 35764198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
    Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation.
    Bao W; Sun H; Wu X; Xu J; Zhang H; Cao L; Fan Y
    Dis Markers; 2022; 2022():1927688. PubMed ID: 36284987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats.
    Zhang Y; Zhou G; Peng Y; Wang M; Li X
    J Ethnopharmacol; 2020 Jan; 247():112273. PubMed ID: 31586692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway.
    Diao H; Cheng J; Huang X; Huang B; Shao X; Zhao J; Lan D; Zhu Q; Yan M; Zhang Y; Rong X; Guo J
    J Ethnopharmacol; 2022 Jul; 293():115261. PubMed ID: 35447198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.